Intellia Therapeutics

Filed a patent for "cd70 car-t compositions and methods for cell-based therapy" on Mon, August 14, 2023

Filed a patent for "compositions and methods for genetically modifying transforming growth factor beta receptor type 2 (tgfbr2)" on Mon, August 14, 2023

Filed a patent for "compositions and methods for genetically modifying cd70" on Mon, August 14, 2023

Filed a patent for "compositions and methods for genetically modifying transforming growth factor beta receptor type 2 (tgfbr2)" on Mon, August 14, 2023

Filed a patent for "compositions and methods for genetically modifying transforming growth factor beta receptor type 2 (tgfbr2)" on Tue, August 15, 2023

Filed a patent for "compositions and methods for genetically modifying transforming growth factor beta receptor type 2 (tgf¿r2)" on Fri, December 15, 2023

Filed a patent for "cd70 car-t compositions and methods for cell-based therapy" on Fri, December 15, 2023

Filed a patent for "compositions and methods for genetically modifying cd70" on Fri, December 15, 2023

Filed a patent for "compositions and methods for treatment of diseases associated with trinucleotide repeats in transcription factor four" on Thu, January 23, 2025

Filed a patent for "assay for confirming the identity of a ribonucleic acid (rna) molecule" on Tue, June 13, 2023

Filed a patent for "compositions and methods for proprotein convertase subtilisin kexin 9 (pcsk9) editing" on Wed, December 21, 2022

Filed a patent for "methods for analyzing nucleic acid cargos of lipid nucleic acid assemblies" on Thu, December 22, 2022

Filed a patent for "systems and methods for genomic editing" on Fri, December 23, 2022

Filed a patent for "compositions and methods for hepatitis b virus (hbv) genome editing" on Mon, March 6, 2023

Filed a patent for "cish compositions and methods for immunotherapy" on Tue, March 7, 2023

Filed a patent for "ionizable amine lipids" on Fri, May 19, 2023

Filed a patent for "ionizable amine lipids" on Fri, December 15, 2023

Filed a patent for "ionizable amine lipids" on Thu, May 16, 2024

Filed a patent for "lipid nanoparticle compositions" on Tue, October 17, 2023

Filed a patent for "engineered t cells" on Wed, June 29, 2022

Filed a patent for "methods for in vivo editing of klkb1" on Fri, July 8, 2022

Filed a patent for "crispr-mediated transgene insertion in neonatal cells" on Fri, July 29, 2022

Filed a patent for "compositions and methods for kallikrein (klkb1) gene editing" on Thu, September 21, 2023

Filed a patent for "lipid nanoparticle formulations for crispr/cas components" on Thu, June 29, 2023

Filed a patent for "modified guide rnas" on Thu, September 14, 2023